What does biomaterials and other — net sales mean?

This metric represents the total revenue generated from the sale of products within the company's biomaterials and ancillary business units. It reflects the commercial performance of non-core or specialized chemical and material offerings derived from wood-based feedstocks. Monitoring this figure helps investors assess the company's diversification strategy and the market adoption of its emerging sustainable material technologies.

Rayonier Advanced Materials (RYAM) Biomaterials and other — Net Sales

Screener

Other segment segments

Cellulose Specialties

$188.51M-5.8%

Cellulose Commodities

$100.98M+72.7%

Paperboard

$48.38M+4.2%

High Yield Pulp

$26.28M+21.9%

Similar metrics at other companies

MBUUPart and other sales — Net Sales

$4.93M-3.0%

AVN

AVNSCorporate and other — Net Sales

$1.9M-81.4%

WMTFuel and other — Net Sales

$3.44B+20.8%

PLCEInternational and other — Net Sales

$40.92M-28.2%

KWRMetalworking and other — Net Sales

$328.55M+11.1%

AVYApparel and other — Net Sales

$438M-3.7%

Other financials

Income statement

See full

Revenue$376.1M+10.6%

Gross profit$22.9M-2.9%

Operating income-$6.3M-374%

Net income-$32.8M+91.0%

EPS (diluted)-$0.49+91.0%

Balance sheet

See full

Cash & equivalents$57.0M-19.3%

Total debt$804.6M+0.4%

Total equity$194.8M-43.1%

Total assets$1.6B-7.7%

Cash flow

See full

Operating cash flow$5.0M—

CapEx$25.4M-32.3%

Free cash flow-$20.3M+69.9%

Valuation

See full

Market cap$610.15M+104%

Enterprise value$1.36B+31.8%

P/S0.4×+0.2×

Profitability

See full

Gross margin5.9%-2.6pp

Operating margin-3.5%-12.7pp

Net margin-9.5%-3.8pp

FCF margin-5.5%-11.0pp

Returns & leverage

See full

Return on equity-52.1%-13.7pp

Debt / equity4.1×+1.8×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Rayonier Advanced Materials in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Rayonier Advanced Materials’s 10-Q, filed August 5, 2026.

Filed: Aug 5, 2026, 12:04 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001597672-26-000029

Line item	Three Months Ended / June 27, 2026	Three Months Ended / June 28, 2025	Six Months Ended / June 27, 2026	Six Months Ended / June 28, 2025
High Purity Cellulose
Cellulose Specialties	$188,508	$200,126	$336,580	$394,678
Cellulose Commodities	100,980	58,484	203,191	131,326
Biomaterials and other	11,974	13,350	24,592	27,978
Total High Purity Cellulose	301,462	271,960	564,363	553,982
Paperboard & High Yield Pulp
Paperboard	48,381	46,451	90,107	95,644
High Yield Pulp	26,283	21,568	40,650	46,260

Item 1. Financial Statements (Unaudited)

FAQ

What is Rayonier Advanced Materials's biomaterials and other — net sales?: Rayonier Advanced Materials (RYAM) reported biomaterials and other — net sales of $11.97M in Q2 2026.
What does biomaterials and other — net sales mean?: This metric represents the total revenue generated from the sale of products within the company's biomaterials and ancillary business units. It reflects the commercial performance of non-core or specialized chemical and material offerings derived from wood-based feedstocks. Monitoring this figure helps investors assess the company's diversification strategy and the market adoption of its emerging sustainable material technologies.